Cubist Pharmaceuticals, a biopharmaceutical company, has opened a new, 35,000sqft research facility at the company's headquarters in Lexington.
Subscribe to our email newsletter
The laboratory will accommodate more than 100 employees focused on the discovery of important new molecules to treat serious diseases, the company said.
Steven Gilman, chief scientific officer of Cubist, said: “The additional lab space expands our discovery research and early development capabilities to meet our current and future needs. This progressive lab space provides for Cubist’s expanding scientific community, and at the same time employs the latest environmentally-friendly construction techniques and advanced energy conservation management and materials.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.